Insight Molecular Diagnostics Inc. (IMDX) Live Share Price, Invest From India

Insight Molecular Diagnostics Inc. Stock Performance

as on June 27, 2026 at 2:15 pm IST

Day's Low
Day's High
$5.27
Day's Price Range
$5.72
$5.40
2.41%
Downside
5.93%
Upside
52 Week's Low
52 Week's High
$2.33
52-Week Price Range
$8.51
$5.40
56.85%
Downside
57.59%
Upside

Insight Molecular Diagnostics Inc. share price movements today

Previous Close: $5.59
Open: $5.41
Volume: 292.3K
Day's Low - High: $5.27 - $5.72
52 Week Low - High: $2.33 - $8.51

Insight Molecular Diagnostics Inc. Historical Returns

1 Month Return: -13.2 %
3 Month Return: + 36.01 %
1 Year Return: + 65.88 %
3 Year Return: 0 %
5 Year Return: 0 %

Insight Molecular Diagnostics Inc. Stock Fundamentals & Key Indicators

Check Insight Molecular Diagnostics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$179.7M

EPS (TTM)

-0.85

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-23603.11%

Insight Molecular Diagnostics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Insight Molecular Diagnostics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Insight Molecular Diagnostics Inc.	NA	$179.7M	NA	NA	0.00%	NA
Agilent Technologies Inc.	BUY	$37.2B	-7.99%	26.43	19.55%	0.79%
IDEXX Laboratories Inc.	BUY	$43.3B	-10.59%	40.5	24.63%	NA
Thermo Fisher Scientific Inc.	BUY	$182.9B	2.61%	27.03	15.15%	0.37%
Danaher Corporation	BUY	$133.7B	-27.52%	36.6	14.89%	0.76%

Stock Returns calculator for Insight Molecular Diagnostics Inc. Stock including INR - Dollar returns

The Insight Molecular Diagnostics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Insight Molecular Diagnostics Inc. investment value today

Current value as on today

₹1,76,317

Returns

₹76,317

(+76.32%)

Returns from Insight Molecular Diagnostics Inc. Stock

₹60,237 (+60.24%)

Dollar Impact

₹16,080 (+16.08%)

Indian Investors' Interest in Insight Molecular Diagnostics Inc. Stock

Search interest for Insight Molecular Diagnostics Inc. Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 30, 2026 to June 29, 2026

Change:-34% versus previous 30 day period

Insight Molecular Diagnostics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	0	0	0	1	2	0	0	1	0
Gross Profit	0	0	0	0	0	1	0	0	0	0
Operating Income	-6	-9	-4	-13	-33	-6	-9	-11	-9	-10
EBITDA	-6	-8	-4	-13	-32	-6	-9	-10	-22	-3
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-9	-4	-13	-33	-6	-9	-10	-22	-4
Income Tax Expense	0	8	-	-	-	-	-	-	-	-
Net Income	-6	-9	-4	-13	-33	-6	-9	-10	-22	-4
Net Profit Margin	-1512.59%	-5186.93%	-4355.77%	-11733.04%	-2255.11%	-312.02%	-1880.69%	-4174.62%	-2015.36%	-13406.25%

Insight Molecular Diagnostics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	1	2	0	1	1	4
Gross Profit	0	1	0	0	0	0
Operating Income	-29	-53	-17	-25	-61	-30
EBITDA	-30	-48	-13	-23	-59	-47
Interest Expense	0	0	0	0	0	0
Depreciation	-	4	5	1	1	2
Income Before Tax	-31	-52	-18	-24	-60	-50
Income Tax Expense	-1	-9	54	-	-	-
Net Income	-29	-64	-72	-27	-60	-50
Net Profit Margin	-2461.51%	-2916.15%	-7609.81%	-1848.37%	-3225.04%	-1238.52%

Insight Molecular Diagnostics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-9	-4	-13	-33	-6	-9	-10	-22	-4
Operating Cash Flow	-3	-5	-5	-5	-5	-6	-4	-5	-7
Investing Cash Flow	0	0	0	0	0	0	-1	-1	0
Financing Cash Flow	0	9	0	10	28	0	0	0	24
Change in Cash	-3	3	-5	5	22	-6	-5	-7	16

Insight Molecular Diagnostics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-19	-15	-22	-29	-64	-72	-27	-60	-50
Operating Cash Flow	-13	-11	-19	-25	-35	-45	-23	-20	-22
Investing Cash Flow	0	0	-12	-11	-13	-4	0	0	-3
Financing Cash Flow	9	12	47	22	78	35	12	20	28
Change in Cash	-2	0	15	-14	28	-14	-12	0	3

Global Institutional Holdings in Insight Molecular Diagnostics Inc.

Funds	Holdings
Northern Trust Corp	0.15%
683 Capital Management LLC	0.09%
Vanguard Capital Management, LLC	1.66%
Heights Capital Management Inc	1.22%
PURA VIDA INVESTMENTS, LLC	2.93%

See all

Insights on Insight Molecular Diagnostics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, IMDX has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -22.95M → -4.29M (in $), with an average increase of 435.1% per quarter
POSITIVE IMPACT
Price Rise
In the last 3 months, IMDX stock has moved up by 51.7%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, IMDX has outperformed top 5 stocks with highest market-cap in its industry
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.13M → 32.0K (in $), with an average decrease of 97.2% per quarter

About Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The company also offers GraftAssureCore test, a blood test designed to measure dd-cfDNA using a novel PCR-based measurement platform, for potential patient registrants; GraftAssureIQ, a transplant monitoring assay to measure the donor-derived cell-free DNA; and GraftAssureDx, a decentralized transplant monitoring levels of donor-derived cell-free DNA in plasma following kidney transplantation to aid in the assessment of the probability of allograft rejection at the time of testing in conjunction with standard clinical assessments. In addition, it provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. for the development and commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. The company was formerly known as OncoCyte Corporation and changed its name to Insight Molecular Diagnostics Inc. in June 2025. Insight Molecular Diagnostics Inc. was incorporated in 2009 and is based in Nashville, Tennessee.

Organisation	Insight Molecular Diagnostics Inc.
Headquarters	2 International Plaza Dr., Nashville, TN, United States, 37217
Industry	Diagnostics & Research
CEO	Mr. Joshua Riggs
E-voting on shares	Click here to vote

Key Management of Insight Molecular Diagnostics Inc.

Name	Title
Ms. Andrea Susan James	Chief Financial Officer
Mr. Yuh-Min Chiang Ph.D.	Chief Technology Officer
Dr. Ekkehard Schutz M.D., Ph.D.	Chief Science Officer
Ms. Sandra O'Donald	Senior Vice President of Business Operations
Dr. Paul R. Billings FACP, M.D., Ph.D.	Consulting Chief Medical Officer
Mr. Joshua Riggs	President, CEO & Director
Mr. Peter Hong	VP, General Counsel & Secretary
Mr. Steven Tahmooressi	Vice President of Marketing
Dr. Michael D. West Ph.D.	Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc.
Mr. James Liu	VP of Accounting, Treasurer, Controller & Principal Accounting Officer

FAQs

What is Insight Molecular Diagnostics Inc. share price today?

Insight Molecular Diagnostics Inc. share price today is $5.4 as on June 27, 2026 at 8:45 am IST at the close of the market. Insight Molecular Diagnostics Inc. share today touched a day high of $5.72 and a low of $5.27.

What is the 52 week high and 52 week low for Insight Molecular Diagnostics Inc. share?

Insight Molecular Diagnostics Inc. share touched a 52 week high of $8.51 on November 12, 2025 and a 52 week low of $2.33 on August 29, 2025. Insight Molecular Diagnostics Inc. stock price today i.e. June 27, 2026 at 8:45 am IST is closed at $5.4,which is 36.55% down from its 52 week high and 131.76% up from its 52 week low.

What is Insight Molecular Diagnostics Inc.'s market capitalisation today?

Insight Molecular Diagnostics Inc. market capitalisation is $0.00T as on June 27, 2026 at 8:45 am IST.

How to invest in Insight Molecular Diagnostics Inc. Stock (IMDX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Insight Molecular Diagnostics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Insight Molecular Diagnostics Inc. Shares that will get you 0.2778 shares as per Insight Molecular Diagnostics Inc. share price of $5.4 per share as on June 27, 2026 at 8:45 am IST.

What is the minimum amount required to buy Insight Molecular Diagnostics Inc. Stock (IMDX) from India?

Indian investors can start investing in Insight Molecular Diagnostics Inc. (IMDX) shares with as little as ₹94.3 or $1 (as of June 29, 2026 at 2:58 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Insight Molecular Diagnostics Inc. stock (as per the Rupee-Dollar exchange rate as on June 29, 2026 at 2:58 am IST). Based on Insight Molecular Diagnostics Inc. share’s latest price of $5.4 as on June 27, 2026 at 8:45 am IST, you will get 1.8519 shares of Insight Molecular Diagnostics Inc.. Learn more about fractional shares .